EHAVE, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.2M
- Price
- $0.0015
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 84.7K
About
Established in 2011 and headquartered in Miami, Florida, EHAVE, Inc. is a healthcare company concentrating on the development of medical psychedelics and an integrated mental health data platform. This platform is designed to work with both the company's proprietary and third-party digital assessment and therapeutic applications, primarily in Canada. EHAVE provides clinically validated digital rehabilitation and assessment software for patients, including its MegaTeam and Ninja Reflex products. Furthermore, it adapts various custom and third-party clinically proven digital solutions to enhance patient engagement and data modeling. A significant offering is the Ehave Dashboard, a mental health informatics platform that empowers clinicians to make objective, data-driven decisions through insights powered by blockchain technology. The company also offers a platform enabling medical practitioners to deliver healthcare services to patients in their homes. Its comprehensive technology solutions are utilized by clinicians, patients, researchers, pharmaceutical firms, and payors.
Quick stats
Shares outstanding1.5B
Computed float443.6M
Float / shares29.9%
Key info
SectorTechnology
IndustrySoftware - Application
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001653606
Websitehttps://www.ehave.com
AI Summary
AI-generated1/6
minorneutralm and a
AIBotics and Empulser Position ‘Power. Persistence. Autonomy.’ Strategy as Pentagon Accelerates Autonomous Warfare Capabilities
AIBotics tied its pending acquisition of Empulser Enterprises, a wireless-power and autonomous-systems defense-technology company, to the Pentagon's newly announced Autonomous Warfare Command and Project Agincourt.
The release is largely strategic positioning: Empulser's products remain in development, with testing, certification, customer adoption and commercialization all subject to engineering, financing and execution.
Forward-looking disclosures reference potential dilution from Series C Preferred Stock conversion, earn-out milestones, discretionary pre-closing loans, and a proposed management transition to Patrick Tsang as CEO, none of which is yet assured.
Red flags
- acquisition is pending and may not close; conditions include audited financials, filing status and due-diligence/termination rights
- potential dilution from conversion of Series C Preferred Stock
- earn-out consideration subject to milestone achievement and setoff/cancellation
- proposed CEO appointment of Patrick Tsang is contingent on conditions
- Empulser products are pre-commercialization with financing and execution risk
- promotional tone riding DoD policy headlines with no disclosed revenue, customers, or contract figures